Literature DB >> 36087076

Advances in the management of liver and biliary tumors.

William R Jarnagin1, Michael I D'Angelica1.   

Abstract

Over the past 50 years, the management of liver and biliary tumors has evolved significantly. Initially considered highly morbid and lethal, resection is now the treatment of choice for a significant proportion of patients with malignant and benign hepatobiliary disease. Improved operative/anesthetic techniques, use of parenchymal-sparing approaches, better patient selection for surgery, effective liver-directed therapies, and new insights into tumor biology are significant contributors to our transformed approach to hepatobiliary neoplasms.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  biliary cancer; cholangiocarcinoma; gallbladder cancer; hepatic colorectal metastasis; hepatocellular carcinoma; liver cancer

Mesh：

Year:  2022        PMID： 36087076      PMCID： PMC9469504          DOI： 10.1002/jso.27039

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   2.885


  30 in total

1.  Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.

Authors:  Bas Groot Koerkamp; Eran Sadot; Nancy E Kemeny; Mithat Gönen; Julie N Leal; Peter J Allen; Andrea Cercek; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Michael I D'Angelica
Journal:  J Clin Oncol       Date:  2017-04-20       Impact factor: 44.544

2.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

3.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

5.  Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.

Authors:  Andrea Cercek; Taryn M Boucher; Jill S Gluskin; Ariel Aguiló; Joanne F Chou; Louise C Connell; Marinela Capanu; Diane Reidy-Lagunes; Michael D'Angelica; Nancy E Kemeny
Journal:  J Surg Oncol       Date:  2016-08-26       Impact factor: 3.454

6.  Analysis of the extent of resection for adenocarcinoma of the gallbladder.

Authors:  Michael D'Angelica; Kimberly Moore Dalal; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2008-11-05       Impact factor: 5.344

7.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

Review 8.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

9.  Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.

Authors:  T Peter Kingham; Camilo Correa-Gallego; Michael I D'Angelica; Mithat Gönen; Ronald P DeMatteo; Yuman Fong; Peter J Allen; Leslie H Blumgart; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-12-27       Impact factor: 6.113

10.  Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Authors:  Nikolaus Schultz; Ghassan K Abou-Alfa; James J Harding; Subhiksha Nandakumar; Joshua Armenia; Danny N Khalil; Melanie Albano; Michele Ly; Jinru Shia; Jaclyn F Hechtman; Ritika Kundra; Imane El Dika; Richard K Do; Yichao Sun; T Peter Kingham; Michael I D'Angelica; Michael F Berger; David M Hyman; William Jarnagin; David S Klimstra; Yelena Y Janjigian; David B Solit
Journal:  Clin Cancer Res       Date:  2018-10-29       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.